Abi Vijenthira (A Vijenthira)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Coronavirus Disease

Diffuse Large B Cell Lymphoma

Systematic Review

Top Venues

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Abi Vijenthira, Andrew Calzavara, Chenthila Nagamuthu, Yosuf Kaliwal, Ning Liu, Danielle Blunt, Shabbir Alibhai, Anca Prica, Matthew C Cheung, Lee Mozessohn
Health care utilization and costs for frail vs nonfrail patients with diffuse large B-cell lymphoma. Blood advances 8 (17) (2024)
Abi Vijenthira, A S Wilton, S Lee, G H Tang, T Gomes, James B Bussel, M Sholzberg
Increased risk of haematological malignancy in adults over age 60 with thrombocytopenia compared with matched controls: Time for an upfront bone marrow evaluation? British journal of haematology (2024)
Abi Vijenthira, Andrew Calzavara, Chenthila Nagamuthu, Yosuf Kaliwal, Ning Liu, Danielle Blunt, Shabbir Alibhai, Anca Prica, Matthew C Cheung, Lee Mozessohn
Health care utilization and costs for frail vs nonfrail patients with diffuse large B-cell lymphoma. Blood advances 8 (17) (2024)
Abi Vijenthira, Andrew Calzavara, Chenthila Nagamuthu, Yosuf Kaliwal, Ning Liu, Danielle Nicole Blunt, Shabbir Mh Alibhai, Anca Prica, Matthew C Cheung, Lee Mozessohn
Healthcare utilization and costs in frail versus non-frail patients with diffuse large B-cell lymphoma. Blood advances (2024)
Lisa K Hicks, Abi Vijenthira
COVID-19 and blood cancer in the vaccination era. Blood 140 (26) (2023)
Lisa K Hicks, Abi Vijenthira
COVID-19 and blood cancer in the vaccination era. Blood 140 (26) (2023)
Lisa K Hicks, Abi Vijenthira
COVID-19 and blood cancer in the vaccination era. Blood 140 (26) (2023)
Lisa K Hicks, Abi Vijenthira
COVID-19 and blood cancer in the vaccination era. Blood 140 (26) (2023)
Adam Suleman, Abi Vijenthira, Zhihui Amy Liu, Tran Truong, Alejandro Berlin, Anca Prica, Danielle Rodin
Virtual Care During the COVID-19 Pandemic for Patients With Hematologic Malignancies: A Single-Institution Experience. JCO oncology practice (2023)
Abi Vijenthira, John Kuruvilla, Michael Crump, Michael D Jain, Anca Prica
Cost-Effectiveness Analysis of Frontline Polatuzumab-Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone and/or Second-Line Chimeric Antigen Receptor T-Cell Therapy Versus Standard of Care for Treatment of Patients With Intermediate- to High-Risk Diffuse Large B-Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Abi Vijenthira, Rebecca Starkman, Yulia Lin, Simon J Stanworth, David Bowen, Lea Harrison, Sophie Wintrich, Jeannie Callum, Rena Buckstein
Multi-national survey of transfusion experiences and preferences of patients with myelodysplastic syndrome. Transfusion 62 (7) (2022)
Abi Vijenthira, Inna Y Gong, Stephen D Betschel, Matthew Cheung, Lisa K Hicks
Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients. Blood advances 5 (12) (2021)